<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://articlefeeds.nasdaq.com/~d/styles/itemcontent.css"?><rss xmlns:a10="http://www.w3.org/2005/Atom" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0">
  <channel xmlns:nasdaq="http://nasdaq.com/reference/feeds/1.0/">
    <title>Latest Articles about GTXI</title>
    <description />
    <language>EN-US</language>
    <lastBuildDate>Sat, 18 May 2013 20:08:26 -0400</lastBuildDate>
    <atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://articlefeeds.nasdaq.com/nasdaq/symbols?symbol=GTXI" /><feedburner:info uri="nasdaq/symbols" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><item xml:base="http://www.nasdaq.com/article/array-presents-arry520-data-analyst-blog-cm235699">
      <guid isPermaLink="false">235699</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_9ePafT3VeU/array-presents-arry520-data-analyst-blog-cm235699</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Array Presents ARRY-520 Data - Analyst Blog</title>
      <description>Array BioPharma, Inc.  (  ARRY  ) recently presented data on ARRY-520 from two ongoing studies in multiple myeloma.  In 2012, Array BioPharma made progress on its proprietary programs ARRY-614&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/_9ePafT3VeU" height="1" width="1"/&gt;</description>
      <pubDate>Thu, 11 Apr 2013 03:09:13 Z</pubDate>
      <a10:updated>2013-04-11T00:08:29Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>ARRY</nasdaq:tickers>
      <nasdaq:tickers>GTXI</nasdaq:tickers>
      <nasdaq:tickers>ONXX</nasdaq:tickers>
      <nasdaq:tickers>TKPYY</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/array-presents-arry520-data-analyst-blog-cm235699</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/cytokinetics-begins-ck2127107-study-analyst-blog-cm234280">
      <guid isPermaLink="false">234280</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JUUpWQxYgqU/cytokinetics-begins-ck2127107-study-analyst-blog-cm234280</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Cytokinetics Begins CK-2127107 Study - Analyst Blog</title>
      <description>Cytokinetics Inc.  (  CYTK  ) recently initiated a phase I study of CK-2127107 in healthy male volunteers. Cytokinetics is evaluating CK-2127107 for the potential improvement of the functions&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/JUUpWQxYgqU" height="1" width="1"/&gt;</description>
      <pubDate>Sat, 06 Apr 2013 01:08:28 Z</pubDate>
      <a10:updated>2013-04-05T22:10:39Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>AMGN</nasdaq:tickers>
      <nasdaq:tickers>CYTK</nasdaq:tickers>
      <nasdaq:tickers>GTXI</nasdaq:tickers>
      <nasdaq:tickers>SHPG</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/cytokinetics-begins-ck2127107-study-analyst-blog-cm234280</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/santarus-tops-focus-on-zegerid-analyst-blog-cm225899">
      <guid isPermaLink="false">225899</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3TVeGcKIdpM/santarus-tops-focus-on-zegerid-analyst-blog-cm225899</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Santarus Tops, Focus on Zegerid - Analyst Blog</title>
      <description>Santarus, Inc.  (  SNTS  ) reported fourth quarter 2012 earnings of 8 cents per share, well above the year-ago earnings of 3 cents per share and the Zacks Consensus Estimate of 1 cent per&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/3TVeGcKIdpM" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 11 Mar 2013 22:09:49 Z</pubDate>
      <a10:updated>2013-03-11T19:13:13Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>ARRY</nasdaq:tickers>
      <nasdaq:tickers>CLDX</nasdaq:tickers>
      <nasdaq:tickers>GTXI</nasdaq:tickers>
      <nasdaq:tickers>HAE</nasdaq:tickers>
      <nasdaq:tickers>SNTS</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/santarus-tops-focus-on-zegerid-analyst-blog-cm225899</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/weekly-ceo-sells-highlight-gtx-inc-vivus-inc-time-warner-inc-cm157631">
      <guid isPermaLink="false">157631</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qG_MZSOVY44/weekly-ceo-sells-highlight-gtx-inc-vivus-inc-time-warner-inc-cm157631</link>
      <category>Investing</category>
      <title>Weekly CEO Sells Highlight: GTx, Inc, VIVUS, Inc, Time Warner Inc.</title>
      <description>According to  GuruFocus Insider Data  , these are the largest CEO sales during the past week: GTx, Inc, VIVUS, Inc, Time Warner Inc.  GTx, Inc. (  GTXI  ): CEO, 10% Owner Mitchell Shuster&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/qG_MZSOVY44" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 23 Jul 2012 07:08:08 Z</pubDate>
      <a10:updated>2012-07-23T04:08:44Z</a10:updated>
      <author>GuruFocus</author>
      <nasdaq:tickers>GTXI</nasdaq:tickers>
      <nasdaq:tickers>TWX</nasdaq:tickers>
      <nasdaq:tickers>VVUS</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/weekly-ceo-sells-highlight-gtx-inc-vivus-inc-time-warner-inc-cm157631</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/premarket-most-active-for-may-8-2012-bac-siri-tef-arna-aig-fosl-bcs-ihg-qqq-fte-gtxi-mako-cm139577">
      <guid isPermaLink="false">139577</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/moQzgiRfCxc/premarket-most-active-for-may-8-2012-bac-siri-tef-arna-aig-fosl-bcs-ihg-qqq-fte-gtxi-mako-cm139577</link>
      <category>News Headlines</category>
      <category>Pre-market Most Active</category>
      <title>Pre-Market Most Active for May 8, 2012 :  BAC, SIRI, TEF, ARNA, AIG, FOSL, BCS, IHG, QQQ, FTE, GTXI, MAKO</title>
      <description>The   NASDAQ 100 Pre-Market Indicator   is down -5.91 to 2,633.37. The total Pre-Market volume is currently 4,034,912 shares traded.        The following are the    most active stocks for the&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/moQzgiRfCxc" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 08 May 2012 16:39:55 Z</pubDate>
      <a10:updated>2012-05-08T13:04:54Z</a10:updated>
      <author>NASDAQ.com News</author>
      <nasdaq:tickers>AIG</nasdaq:tickers>
      <nasdaq:tickers>ARNA</nasdaq:tickers>
      <nasdaq:tickers>BAC</nasdaq:tickers>
      <nasdaq:tickers>BCS</nasdaq:tickers>
      <nasdaq:tickers>FOSL</nasdaq:tickers>
      <nasdaq:tickers>FTE</nasdaq:tickers>
      <nasdaq:tickers>GTXI</nasdaq:tickers>
      <nasdaq:tickers>IHG</nasdaq:tickers>
      <nasdaq:tickers>MAKO</nasdaq:tickers>
      <nasdaq:tickers>QQQ</nasdaq:tickers>
      <nasdaq:tickers>SIRI</nasdaq:tickers>
      <nasdaq:tickers>TEF</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/premarket-most-active-for-may-8-2012-bac-siri-tef-arna-aig-fosl-bcs-ihg-qqq-fte-gtxi-mako-cm139577</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/top-ten-undervalued-stocks-with-large-cash-cushions-cm104000">
      <guid isPermaLink="false">104000</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Rbh2O6q6J4w/top-ten-undervalued-stocks-with-large-cash-cushions-cm104000</link>
      <category>Investing</category>
      <category>Investing Ideas</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Top Ten Undervalued Stocks With Large Cash Cushions</title>
      <description>( Written by Rebecca Lipman. List compiled by Eben Esterhuizen, CFA. Operating expense and cash holdings data sourced from Google Finance, EPS data sourced from Yahoo! Finance.)   Analyst target&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/Rbh2O6q6J4w" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 22 Nov 2011 07:16:18 Z</pubDate>
      <a10:updated>2011-11-22T02:16:20Z</a10:updated>
      <author>Kapitall</author>
      <nasdaq:tickers>ACHN</nasdaq:tickers>
      <nasdaq:tickers>ARIA</nasdaq:tickers>
      <nasdaq:tickers>EXEL</nasdaq:tickers>
      <nasdaq:tickers>GTXI</nasdaq:tickers>
      <nasdaq:tickers>ICON</nasdaq:tickers>
      <nasdaq:tickers>INSP</nasdaq:tickers>
      <nasdaq:tickers>MAPP</nasdaq:tickers>
      <nasdaq:tickers>PACB</nasdaq:tickers>
      <nasdaq:tickers>ZIOP</nasdaq:tickers>
      <nasdaq:tickers>GEVO</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/top-ten-undervalued-stocks-with-large-cash-cushions-cm104000</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/limit-your-risk-smart-money-stock-picks-in-strong-cash-positions-cm102590">
      <guid isPermaLink="false">102590</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2IIaUEtSULY/limit-your-risk-smart-money-stock-picks-in-strong-cash-positions-cm102590</link>
      <category>Investing</category>
      <category>Investing Ideas</category>
      <category>Stocks</category>
      <category>US Markets</category>
      <title>Limit Your Risk: Smart Money Stock Picks in Strong Cash Positions</title>
      <description>(Written by Alexander Crawford. Accounting data sourced from Google Finance, institutional data sourced from Fidelity, insider data sourced from Yahoo! Finance.)   Since the recession,&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/2IIaUEtSULY" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 15 Nov 2011 06:25:34 Z</pubDate>
      <a10:updated>2011-11-15T01:25:36Z</a10:updated>
      <author>Kapitall</author>
      <nasdaq:tickers>ALIM</nasdaq:tickers>
      <nasdaq:tickers>GNOM</nasdaq:tickers>
      <nasdaq:tickers>GTXI</nasdaq:tickers>
      <nasdaq:tickers>MDW</nasdaq:tickers>
      <nasdaq:tickers>THLD</nasdaq:tickers>
      <nasdaq:tickers>FUR</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/limit-your-risk-smart-money-stock-picks-in-strong-cash-positions-cm102590</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/biotech-exit-rush-investors-are-freaked-out-by-biotechs-hurdles-cm96669">
      <guid isPermaLink="false">96669</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3YLc-Wgmpko/biotech-exit-rush-investors-are-freaked-out-by-biotechs-hurdles-cm96669</link>
      <category>Investing</category>
      <category>Investing Ideas</category>
      <category>Stocks</category>
      <title>Biotech Exit Rush: Investors Are Freaked Out by Biotech's Hurdles</title>
      <description>(Written by Alexander Crawford, list compiled by Eben Esterhuizen, CFA. Institutional data sourced from Fidelity, insider data sourced from Yahoo! Finance.)   No longer does FDA drug approval&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/3YLc-Wgmpko" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 03 Oct 2011 04:05:11 Z</pubDate>
      <a10:updated>2011-10-03T00:05:13Z</a10:updated>
      <author>Kapitall</author>
      <nasdaq:tickers>GNOM</nasdaq:tickers>
      <nasdaq:tickers>GTXI</nasdaq:tickers>
      <nasdaq:tickers>IDIX</nasdaq:tickers>
      <nasdaq:tickers>SQNM</nasdaq:tickers>
      <nasdaq:tickers>THRX</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/biotech-exit-rush-investors-are-freaked-out-by-biotechs-hurdles-cm96669</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/options-ideas-24-healthcare-stocks-with-bullish-options-sentiment-cm79464">
      <guid isPermaLink="false">79464</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JzL4GNTcuHs/options-ideas-24-healthcare-stocks-with-bullish-options-sentiment-cm79464</link>
      <category>Investing</category>
      <category>Investing Ideas</category>
      <category>Stocks</category>
      <title>Options Ideas: 24 Healthcare Stocks With Bullish Options Sentiment</title>
      <description>Are you looking to boost your exposure to the healthcare sector? If so, this may be an interesting starting point for you own analysis.  To construct this list we looked for stocks with three&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/JzL4GNTcuHs" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 07 Jun 2011 21:15:59 Z</pubDate>
      <a10:updated>2011-06-07T17:40:55Z</a10:updated>
      <author>Kapitall</author>
      <nasdaq:tickers>ACOR</nasdaq:tickers>
      <nasdaq:tickers>ALNY</nasdaq:tickers>
      <nasdaq:tickers>ALXN</nasdaq:tickers>
      <nasdaq:tickers>AMAG</nasdaq:tickers>
      <nasdaq:tickers>GTXI</nasdaq:tickers>
      <nasdaq:tickers>KCI</nasdaq:tickers>
      <nasdaq:tickers>LNCR</nasdaq:tickers>
      <nasdaq:tickers>NPSP</nasdaq:tickers>
      <nasdaq:tickers>SHPGY</nasdaq:tickers>
      <nasdaq:tickers>VOLC</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/options-ideas-24-healthcare-stocks-with-bullish-options-sentiment-cm79464</feedburner:origLink></item>
  </channel>
</rss>
